05:30 AM EDT, 05/05/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Our 12-month target price for Anheuser-Busch InBev ( BUD ) is raised to USD94 (from USD92). This implies a 20.8x 2026 P/E, a premium to the industry forward average of 12.5x and its five-year historical average of 17.6x. Our relative valuation reflects ABI's improved financial position, both in terms of profitability and indebtedness, which should translate into meaningful profit. We like ABI for its industry-leading margins (LTM EBIT margin: 26.4% vs. peers' average: 17.4%), which is expected to gain further on improving volume outlook. We raise our 2026 EPADS estimate to USD4.50 (from USD4.41) and 2027's to USD5.08 (from USD4.95). We think that forex transactional headwinds will continue to be an issue moving forward, but will not deter ABI from sustaining its growth momentum given evidence of strong volume recovery and positive development across its strategic drivers. We remain confident in ABI's growth trajectory given its global portfolio strength and resilient market share across its key markets.